Temporal trends in healthcare resource utilization and costs following acute myocardial infarction

Arthur Shiyovich1,2, Harel Gilutz3, Jonathan Eli Arbelle3,4

  • 1Department of Cardiology, Beilinson Hospital, Rabin Medical Center, Rabin Medical Center, 39 Jabotinski Street, 49100, Petah Tikva, Israel. arthur.shiyovich@gmail.com.

Insights

Healthcare resource utilization decreased after acute myocardial infarction (AMI), but costs remained stable. Further analysis of long-term resource allocation and enhanced ambulatory follow-up for secondary prevention are recommended.

Area of Science:

  • Cardiology
  • Health Economics
  • Healthcare Management

Background:

  • Acute myocardial infarction (AMI) significantly impacts healthcare resource utilization and expenditure.
  • Understanding long-term trends in resource use and costs post-AMI is crucial for effective healthcare planning.

Purpose of the Study:

  • To analyze temporal trends in healthcare resource utilization and associated costs for patients following AMI between 2003 and 2015.
  • To identify changes in length of hospital stay, emergency department visits, primary care, and ambulatory services utilization and costs.

Main Methods:

  • Retrospective analysis of 8047 patients surviving the first year post-hospitalization for AMI (2002-2012), followed until 2015.
  • Evaluation of annual trends in length of stay (LOS), emergency department (ED) visits, primary care, and outpatient consulting clinic visits.
  • Cost analysis of healthcare resource utilization over the study period.

Main Results:

  • Significant decrease observed in LOS and primary care visits.
  • Increase noted in ED visits and ambulatory services utilization.
  • Overall healthcare costs demonstrated a decreasing trend, with multivariate analysis showing no significant change in total costs despite shifts in service utilization.

Conclusions:

  • Despite reduced utilization of most healthcare services over a decade, overall healthcare expenditure following AMI remained unchanged.
  • Further research into the cost-effectiveness of long-term resource allocation post-AMI is warranted.
  • Emphasis on intensified ambulatory follow-up for secondary prevention and high-quality outpatient chest pain units is recommended.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
154
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
709
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
611
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
296
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
125